中枢神经系统肿瘤患者治疗中的潜在分子靶点
Potential Molecular Targets in the Treatment of Patients with CNS Tumors.
作者信息
Pan Edward
机构信息
Daiichi-Sankyo, Inc., 211 Mt. Airy Road, Basking Ridge, NJ 07920, USA.
出版信息
Cancers (Basel). 2023 Jul 27;15(15):3807. doi: 10.3390/cancers15153807.
Abstract
The challenges in identifying effective therapies for CNS tumors continue to be daunting [...].
摘要
确定中枢神经系统肿瘤有效治疗方法面临的挑战依然艰巨[...]。
相似文献
1
Potential Molecular Targets in the Treatment of Patients with CNS Tumors.中枢神经系统肿瘤患者治疗中的潜在分子靶点
Cancers (Basel). 2023 Jul 27;15(15):3807. doi: 10.3390/cancers15153807.
2
The Road to CAR T-Cell Therapies for Pediatric CNS Tumors: Obstacles and New Avenues.儿童中枢神经系统肿瘤的嵌合抗原受体T细胞疗法之路：障碍与新途径
Front Oncol. 2022 Jan 27;12:815726. doi: 10.3389/fonc.2022.815726. eCollection 2022.
3
EANO guideline on rational molecular testing of gliomas, glioneuronal, and neuronal tumors in adults for targeted therapy selection.EANO 成人胶质瘤、神经胶质神经元和神经元肿瘤靶向治疗选择的合理分子检测指南。
Neuro Oncol. 2023 May 4;25(5):813-826. doi: 10.1093/neuonc/noad008.
4
The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors.聚腺苷二磷酸核糖聚合酶抑制剂在原发性中枢神经系统恶性肿瘤患者中的作用。
Curr Treat Options Oncol. 2022 Nov;23(11):1566-1589. doi: 10.1007/s11864-022-01024-5. Epub 2022 Oct 15.
5
Central nervous system.中枢神经系统。
Cancer Biomark. 2010;9(1-6):193-210. doi: 10.3233/CBM-2011-0177.
6
Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors.提高小儿脑肿瘤的诊断和治疗效果。
Mol Diagn Ther. 2018 Feb;22(1):25-39. doi: 10.1007/s40291-017-0299-3.
7
Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.免疫疗法作为脑和脊髓肿瘤的一种新治疗方法。
Adv Exp Med Biol. 2023;1394:73-84. doi: 10.1007/978-3-031-14732-6_5.
8
Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: A review.可注射温敏水凝胶作为治疗中枢神经系统疾病的药物传递系统：综述。
J Control Release. 2021 Jan 10;329:16-35. doi: 10.1016/j.jconrel.2020.11.049. Epub 2020 Nov 28.
9
Genome-wide molecular characterization of central nervous system primitive neuroectodermal tumor and pineoblastoma.中枢神经系统原始神经外胚层肿瘤和松果体母细胞瘤的全基因组分子特征分析。
Neuro Oncol. 2011 Aug;13(8):866-79. doi: 10.1093/neuonc/nor070.
10
Psychiatric manifestations as initial presentation for pediatric CNS germ cell tumors, a case series.以精神症状为首发表现的儿童中枢神经系统生殖细胞肿瘤：病例系列
Childs Nerv Syst. 2016 Aug;32(8):1359-62. doi: 10.1007/s00381-016-3145-8. Epub 2016 Jun 16.
本文引用的文献
1
Improving Localized Radiotherapy for Glioblastoma via Small Molecule Inhibition of KIF11.通过小分子抑制驱动蛋白家族成员11（KIF11）改善胶质母细胞瘤的局部放疗
Cancers (Basel). 2023 Jun 13;15(12):3173. doi: 10.3390/cancers15123173.
2
Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010-2019 Retrospective Cohort Study.表皮生长因子受体导向的酪氨酸激酶抑制剂（EGFR-TKI）与放疗联合用于非小细胞肺癌脑转移：一项2010 - 2019年回顾性队列研究。
Cancers (Basel). 2023 Jun 1;15(11):3015. doi: 10.3390/cancers15113015.
3
First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases.第一代与第三代表皮生长因子受体酪氨酸激酶抑制剂用于治疗伴有脑转移的表皮生长因子受体突变的非小细胞肺癌患者
Cancers (Basel). 2023 Apr 20;15(8):2382. doi: 10.3390/cancers15082382.
4
DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets.低级别胶质瘤中的DNA甲基化与组蛋白修饰：当前认识与潜在临床靶点
Cancers (Basel). 2023 Feb 20;15(4):1342. doi: 10.3390/cancers15041342.
5
Preclinical Models of Low-Grade Gliomas.低级别胶质瘤的临床前模型
Cancers (Basel). 2023 Jan 18;15(3):596. doi: 10.3390/cancers15030596.
6
GBM Cells Exhibit Susceptibility to Metformin Treatment According to TLR4 Pathway Activation and Metabolic and Antioxidant Status.根据Toll样受体4（TLR4）信号通路激活以及代谢和抗氧化状态，胶质母细胞瘤（GBM）细胞对二甲双胍治疗敏感。
Cancers (Basel). 2023 Jan 18;15(3):587. doi: 10.3390/cancers15030587.
7
Novel Therapeutic Approaches in Neoplastic Meningitis.肿瘤性脑膜炎的新型治疗方法
Cancers (Basel). 2022 Dec 25;15(1):119. doi: 10.3390/cancers15010119.
8
Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study.贝伐单抗用于新诊断胶质母细胞瘤进展后的治疗（BIOMARK）：II期安全性、疗效及生物标志物研究
Cancers (Basel). 2022 Nov 10;14(22):5522. doi: 10.3390/cancers14225522.
9
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness.靶向腺苷作为降低胶质母细胞瘤侵袭性的新策略。
Cancers (Basel). 2022 Aug 20;14(16):4032. doi: 10.3390/cancers14164032.
10
Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways.MYC 扩增的髓母细胞瘤肿瘤的综合代谢谱分析揭示了对氨基酸、三羧酸和己糖胺途径的关键依赖性。
Cancers (Basel). 2022 Mar 3;14(5):1311. doi: 10.3390/cancers14051311.
Zotero 插件